Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987;29(4):380-4.
doi: 10.1007/BF00348919.

Influence of the spread and period of retention of Iotrolan in the subarachnoid space on the side effects rate in myelography

B Hoffmann, H Becker, B I Wenzel-Hora

Influence of the spread and period of retention of Iotrolan in the subarachnoid space on the side effects rate in myelography

B Hoffmann et al. Neuroradiology. 1987.

Abstract

Fifty patients underwent myelography with the newly developed CSF-isotonic, dimeric, non-ionic contrast medium Iotrolan. Repeat spinal and cranial computerised tomographic studies with measurement of the attenuation values were conducted to demonstrate the administered contrast medium in the spinal canal and intracranial subarachnoid space. The patients were examined neurologically, observed clinically and asked about concomitant symptoms. The period of retention and the spread of the contrast medium in the subarachnoid space was not found to have any influence on the side effects rate. In particular, no association was confirmed between intracranially demonstrable contrast medium and the occurrence of side effects.

PubMed Disclaimer

References

    1. Computertomographie. 1982 Dec;2(4):179-83 - PubMed
    1. Rontgenblatter. 1981 May;34(5):185-9 - PubMed
    1. AJR Am J Roentgenol. 1982 Aug;139(2):357-60 - PubMed
    1. Acta Neurol Scand. 1981 May;63(5):315-22 - PubMed
    1. Acta Radiol Diagn (Stockh). 1974 Sep;15(5):497-507 - PubMed